Pricing Log in Create free account

Immix Biopharma, Inc. (IMMX) vs Inventiva S.A. Sponsored ADR (IVA)

Immix Biopharma, Inc. and Inventiva S.A. Sponsored ADR are both Biotechnology companies. Immix Biopharma, Inc. and Inventiva S.A. Sponsored ADR are of similar size ($740.0M and $719.6M). Immix Biopharma, Inc. has the higher net margin (0.00% vs −750.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Immix Biopharma, Inc. leads on 5 and Inventiva S.A. Sponsored ADR on 5.

Valuation

Metric IMMX IVA Biotechnology median
P/E n/m n/m 8.50
P/S n/m 5.79 9.71
P/B 2.22 1.66 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.01 0.64
EV/Sales n/m (0.10) 9.21
Earnings yield (11.03%) (121.19%) (33.15%)
Free cash flow yield (7.68%) (120.95%) (25.50%)

Profitability

Metric IMMX IVA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (750.28%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (34.18%) 0.00% (56.36%)
Return on assets (31.34%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMMX IVA Biotechnology median
Revenue growth (TTM) — 547.89% 6.02%
EPS growth (last fiscal year) (17.11%) 35.44% 30.26%
Revenue growth, 5-year CAGR — 8.33% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMMX IVA Biotechnology median
Debt to equity 0.00 1.13 0.00
Current ratio 25.13 3.81 4.72
Net debt to EBITDA 3.39 0.29 0.96

Dividend

Metric IMMX IVA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMMX IVA Biotechnology median
Market cap 719.59m 739.99m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack